4SC
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
4SC
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1997-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.4sc.de
Total Employee:
51+
Status:
Active
Contact:
+490897007630
Email Addresses:
[email protected]
Total Funding:
94.7 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Cue Biopharma
Cue Biopharma has developed a highly productive platform for the treatment of cancer and autoimmune disease.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Current Employees Featured
Stock Details
Investors List
Santo Holding
Santo Holding investment in Post-IPO Equity - 4SC
Wellington Partners
Wellington Partners investment in Post-IPO Equity - 4SC
Deutsche Venture Capital
Deutsche Venture Capital investment in Series C - 4SC
Mulligan BioCapital
Mulligan BioCapital investment in Series C - 4SC
BionX™ Medical Technologies
BionX™ Medical Technologies investment in Series C - 4SC
3i Group
3i Group investment in Series C - 4SC
Beteiligungsgesellschaft Neue Länder
Beteiligungsgesellschaft Neue Länder investment in Series B - 4SC
BioM AG
BioM AG investment in Series B - 4SC
Deutsche Venture Capital
Deutsche Venture Capital investment in Series B - 4SC
Bayern Kapital
Bayern Kapital investment in Series B - 4SC
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-11-02 | Panoptes Pharma | 4SC investment in Seed Round - Panoptes Pharma | N/A |
| 2008-05-26 | Nexigen | 4SC investment in Funding Round - Nexigen | N/A |
Official Site Inspections
http://www.4sc.de Semrush global rank: 9.75 M Semrush visits lastest month: 113
- Host name: 46.30.63.120
- IP address: 46.30.63.120
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "4SC"
4SC AG - Entwicklung effektiver Medikamente für …
Aug 8, 2024 4SC ist ein innovatives biopharmazeutisches Unternehmen mit Sitz in Planegg-Martinsried bei München, mit Fokus auf Medikamentenentwicklung im Bereich Onkologie. Wir entwickeln neuartige niedermolekulare Medikamente …See details»
4SC - Development of innovative cancer drugs
Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on product development in oncology. We develop novel small molecule drugs for the …See details»
Investoren & Medien - 4SC AG
4SC veröffentlicht Q3 Mitteilung 2024. 11. Sep 2024. 4SC AG beschließt die Ausgabe neuer Aktien mit einem erwarteten Emissionserlös von ca. EUR 4 Millionen. 08. Aug 2024. 4SC …See details»
Company - 4SC AG
Aug 8, 2024 4SC’s goal is to advance its own drug development programs in order to increase the value of the Company as a whole through entering into valuable partnerships with …See details»
Unternehmen - 4SC AG
Oct 17, 2024 Das Ziel von 4SC besteht darin, die eigenen Programme zur Medikamentenentwicklung voranzubringen und die letztendlich zugelassenen Wirkstoffe in …See details»
4SC - Crunchbase Company Profile & Funding
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended …See details»
4SC (company) - 4SC (Unternehmen) - Second Wiki
The 4SC AG is a German biotechnology company. The company, which has been traded in the Prime Standard on the Frankfurt Stock Exchange since December 2005, has its headquarters …See details»
4SC – Wikipedia
Die 4SC AG ist ein deutsches Biotechnologieunternehmen.Die seit Dezember 2005 im Prime Standard an der Frankfurter Börse gehandelte Gesellschaft hat ihren Firmensitz in Planegg …See details»
Investors & Media - 4SC AG
4SC Share Shareholder Structure Financial Calendar Financial Reports Key Figures Conference Calls & Webcasts Analyst Coverage: Conference Calendar. Conferences with participation of …See details»
4SC AG - Bayern International – Competence for International …
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by …See details»
4SC Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 4SC is a biopharmaceutical company developing small-molecule drugs that target key indications in cancer with unmet medical needs. Its current product pipeline includes two …See details»
4sc - Overview, News & Similar companies | ZoomInfo.com
Mar 11, 2020 Who is 4sc. 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. …See details»
Corporate Governance - 4SC AG
Good, transparent corporate governance is a top priority for 4SC. The company is committed to the German Corporate Governance Code with respect to its goals, values and processes. 4SC …See details»
4SC AG berichtet über Ergebnisse des Geschäftsjahres 2022 und ...
Planegg-Martinsried, 17. März 2023 – Die 4SC AG (4SC, FWB Prime Standard: VSC) hat heute die Finanzergebnisse für das am 31. Dezember 2022 abgelaufene Geschäftsjahr und einen …See details»
4SC AG: 4SC: Daten der RESMAIN-Studie werden auf der Tagung …
September 2023 -Die 4SC AG (4SC, FSE Prime Standard: VSC) ein Biotech-Unternehmen, das das Leben von Patienten mit kutanem T-Zell-Lymphom (CTCL) im fortgeschrittenen Stadium …See details»
4SC AG – Company Update
Aug 8, 2024 4SC AG – Company Update Planegg-Martinsried, 20. Dezember 2023 – Die 4SC AG (4SC, FSE Prime Standard: VSC), ein Biotech-Unternehmen, das das Leben von …See details»
4SC (DB:VSC) - Stock Price, News & Analysis - Simply Wall St
4 days ago 4SC AG, a biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany. Its product …See details»
4SC AKTIE | Aktienkurs & News | A3E5C4 - boerse.de
3 days ago 4SC AKTIE (ISIN: DE000A3E5C40): Realtime-Kurs der 4SC Aktie in EUR Analysen & Performance aktuelle Nachrichten ⇒ die nächsten Kursziele.See details»
4SC veröffentlicht Halbjahresbericht und gibt Update
Planegg-Martinsried, 8. August 2024 – Die 4SC AG (4SC, FSE Prime Standard: VSC) hat heute den Halbjahresbericht zum 30. Juni 2024 veröffentlicht, in dem sie die wesentlichen …See details»
Finanzberichte - 4SC AG
Aug 10, 2023 21. März 2018: Geschäftsbericht 2017: Bericht herunterladen: 26. Oktober 2017: 9-Monats-Konzern-Mitteilung (Q3/2017) Bericht herunterladen: 10. August 2017See details»